Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortTwo-drug antibiotic for UTIs and pneumocystis.First choice for simple bladder infections.
Body systemAntibioticsAntibiotics
Drug classSulfonamide combinationsNitrofurans
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesUrinary tract infections, Pneumocystis pneumonia treatment and prevention, MRSA skin infections, Toxoplasmosis preventionUncomplicated cystitis, Preventing recurrent UTIs
How it worksBlocks two steps in the vitamin pathway bacteria depend on.Builds up in urine and attacks bacteria there in several ways at once.
Starts working——
Half-lifeAbout 10 hoursAbout 20 minutes
Typical adult dose960 mg (800/160 mg) twice a day.Modified-release 100 mg twice a day with food for 3 days (women) or 7 days (men).
FormsTablet, Oral suspension, IV infusionCapsule, Modified-release capsule, Oral suspension
Common side effectsNausea, Rash, Loss of appetiteNausea, Headache, Dark yellow or brown urine
Serious side effectsSevere skin reactions (SJS/TEN), High potassium, Blood disorders, Kidney injuryLung reactions (cough, breathlessness), Liver injury with long-term use, Nerve damage
Don't take ifAllergy to sulfonamides; Folate deficiency or blood disorders; Severe kidney or liver impairment; Late pregnancy, newborns under 6 weeksSignificantly reduced kidney function (eGFR below about 45); Allergy to nitrofurantoin; Last weeks of pregnancy and babies under 3 months; G6PD deficiency
AlcoholUsually no problem in moderation. No direct interaction.Usually no problem in moderation. No direct interaction.
PregnancyUsually avoidedAvoided in the first trimester (folate antagonist) and near term, except for HIV-related prevention.Use with cautionFine in early and mid pregnancy; avoid near delivery (risk of anaemia in the baby).
BreastfeedingUse with cautionAvoid in the first weeks after birth, and in G6PD-deficient infants.Use with cautionAvoid in the first weeks after birth and in G6PD-deficient infants.
In use since19681953
Brand namesUnited States: Bactrim, SeptraUnited Kingdom: SeptrinIndia: Septran, BactrimUnited States: Macrobid, MacrodantinUnited Kingdom: Macrobid, MacrodantinIndia: Niftran
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeJ01EE01J01XE01

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker